CAMP4 Therapeutics Corp. (CAMP)
3.94
-0.09
(-2.23%)
USD |
NASDAQ |
Jun 25, 13:43
CAMP4 Therapeutics Cash from Operations (Quarterly) : -10.98M for March 31, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -10.98M |
| December 31, 2025 | 6.293M |
| September 30, 2025 | -11.22M |
| June 30, 2025 | -10.34M |
| March 31, 2025 | -14.29M |
| Date | Value |
|---|---|
| December 31, 2024 | -15.27M |
| September 30, 2024 | -9.693M |
| June 30, 2024 | -13.44M |
| March 31, 2024 | -11.14M |
| December 31, 2023 | -11.78M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 33.98M |
| Alnylam Pharmaceuticals, Inc. | 70.50M |
| Anika Therapeutics, Inc. | -4.846M |
| Savara, Inc. | -33.05M |
| Vericel Corp. | 16.38M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.057M |
| Free Cash Flow | -26.25M |
| Free Cash Flow Per Share (Quarterly) | -0.1896 |
| Free Cash Flow to Equity (Quarterly) | -11.13M |
| Free Cash Flow to Firm (Quarterly) | -10.98M |
| Free Cash Flow Yield | -16.94% |